Home >> Life Sciences >> Pharmaceuticals >> General Pharmaceuticals

Global Sports Medicine Market Outlook (2014-2022)

Published: Jun-2015 | Format: PDF | Stratistics MRC | Number of pages: 90 | Code: MRS - 25451


The Global Sports Medicine Market is accounted $31.5 billion in 2014 and is expected to reach $53.6 billion in 2022 at a Compound Annual Growth Rate of 6.8%. Sports medicine is about preventing and treating the athletes and any other people indulged in physical activities from injuries. The Sports Medicine market is the sub set of the orthopedic market. Some of the key factors driving the market are increasing number of cases of sports injuries, gaining popularity of western sports and growing economies to raise the budget allotment for sports. Whereas factors such as lack of trained professionals and cost of certain products are likely to restraint the market growth. Insurance is posing challenge to sports medicine as it would not cover the sports injuries and reimbursement.

The Global Sports Medicine Market is segmented by procedure type, product type, application and geography. By procedure, it is categorized to Cartilage Reconstruction and Repair, Ligament Reconstruction and Repair, Bone Reconstruction & Repair and Surgery. On the basis of product type, it is segmented to orthopedic products and Recovery products. Orthopedic products are sub categorized to Arthroscopy Devices, Fracture Repair Devices, Artificial implants, Orthobiologics and Soft Tissue Fixation Devices. Recovery Products are sub categorized to Braces, Thermotherapy, Performance Monitoring Devices and Accessories. By application, it is segmented to Shoulder, Knee, Hand and Wrist, Elbow, Foot and Ankle, Hip, Groin and Spine. By geography, it is segmented to North America, Europe, Asia Pacific, and Rest of the World.

Some of the key players in the Sports Medicine Market are Arthrex, Biomet Inc., Arthrocare, Conmed Corporation, Stryker Corporation, Otto Bock Healthcare, DJO Global, Zimmer Holdings Inc., Smith & Nephews and Xiros.

WHAT OUR REPORT OFFERS:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Table of Content

1 EXECUTIVE SUMMARY

2 PREFACE
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL SPORTS MEDICINE MARKET, BY PROCEDURE
5.1 Cartilage Reconstruction and Repair
5.2 Ligament Reconstruction and Repair
5.3 Bone Reconstruction & Repair
5.4 Surgery

6 GLOBAL SPORTS MEDICINE MARKET, BY PRODUCT TYPE
6.1 Orthopedic Products
6.1.1 Arthroscopy Devices
6.1.2 Repair Devices
6.1.3 Artificial implants
6.1.4 Orthobiologics
6.1.5 Soft Tissue Fixation Devices
6.2 Recovery Products
6.2.1 Braces
6.2.2 Thermotherapy
6.2.3 Performance Monitoring Devices
6.2.4 Accessories

7 GLOBAL SPORTS MEDICINE MARKET, BY APPLICATION
7.1 Shoulder
7.2 Knee
7.3 Hand and Wrist
7.4 Elbow
7.5 Foot and Ankle
7.6 Hip
7.7 Groin
7.8 Spine

8 GLOBAL SPORTS MEDICINE MARKET, BY GEOGRAPHY
8.1 North America
8.1.1 US
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia
8.4 Rest of the World
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others

9 KEY DEVELOPMENTS
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 COMPANY PROFILING
10.1 Arthrex
10.2 Biomet Inc.
10.3 Arthrocare
10.4 Conmed Corporation
10.5 Stryker Corporation
10.6 Otto Bock Healthcare
10.7 DJO Global
10.8 Zimmer Holdings Inc.
10.9 Smith & Nephews
10.10 Xiros

Inquiry For Buying



Request Sample




Related Reports

Delta-Like Ligand 4 (DLL4 or Drosophila Delta Homolog 4) - Pipeline Review, H1 2016

Apr-2016 | Global Markets Direct | Pages : 48 | Code : MRS-59711 | 3500

Delta-Like Ligand 4 (DLL4 or Drosophila Delta Homolog 4) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Delta-Like Ligand 4 (DLL4 or Drosophila Delta Homolog 4) - Pipeline Review, H1 2016’, provides in depth analysis on Delta-Like Ligand 4 (DLL4 or Drosophila Delta Homolog 4) targeted pipeline therapeutics. The report provides comprehensive information on the Delta-Like Ligand 4 (DLL4 or Drosophila Delta Homolog 4) , targeted therapeutics, complete with analysis by indicat Read more

Nociceptin Receptor (Kappa-Type 3 Opioid Receptor or KOR-3 or Orphanin FQ Receptor or OPRL1 or OOR or ORL1) - Pipeline Review, H1 2016

Apr-2016 | Global Markets Direct | Pages : 51 | Code : MRS-59710 | 3500

Nociceptin Receptor (Kappa-Type 3 Opioid Receptor or KOR-3 or Orphanin FQ Receptor or OPRL1 or OOR or ORL1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Nociceptin Receptor (Kappa-Type 3 Opioid Receptor or KOR-3 or Orphanin FQ Receptor or OPRL1 or OOR or ORL1) - Pipeline Review, H1 2016’, provides in depth analysis on Nociceptin Receptor (Kappa-Type 3 Opioid Receptor or KOR-3 or Orphanin FQ Receptor or OPRL1 or OOR or ORL1) targeted pipeline therapeutics. The report prov Read more

Gastric Inhibitory Polypeptide Receptor (GIP-R or Glucose-Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H1 2016

Apr-2016 | Global Markets Direct | Pages : 47 | Code : MRS-59709 | 3500

Gastric Inhibitory Polypeptide Receptor (GIP-R or Glucose-Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Gastric Inhibitory Polypeptide Receptor (GIP-R or Glucose-Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H1 2016’, provides in depth analysis on Gastric Inhibitory Polypeptide Receptor (GIP-R or Glucose-Dependent Insulinotropic Polypeptide Receptor or GIPR) targeted pipeline therapeutics. Read more

KiSS-1 Receptor (G-Protein Coupled Receptor 54 or G-Protein Coupled Receptor OT7T175 or hOT7T175 or Hypogonadotropin-1 or Kisspeptins Receptor or Metastin Receptor or KISS1R or GPR54) - Pipeline Review, H1 2016

Apr-2016 | Global Markets Direct | Pages : 34 | Code : MRS-59708 | 3500

KiSS-1 Receptor (G-Protein Coupled Receptor 54 or G-Protein Coupled Receptor OT7T175 or hOT7T175 or Hypogonadotropin-1 or Kisspeptins Receptor or Metastin Receptor or KISS1R or GPR54) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘KiSS-1 Receptor (G-Protein Coupled Receptor 54 or G-Protein Coupled Receptor OT7T175 or hOT7T175 or Hypogonadotropin-1 or Kisspeptins Receptor or Metastin Receptor or KISS1R or GPR54) - Pipeline Review, H1 2016’, provides in depth analysis on KiSS- Read more

Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016

Apr-2016 | Global Markets Direct | Pages : 50 | Code : MRS-59707 | 3500

Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016’, provides in depth analysis on Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) targeted pipeline therapeutics. The report provides comprehensive information on the Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1), targeted ther Read more

Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016

Apr-2016 | Global Markets Direct | Pages : 65 | Code : MRS-59706 | 3500

Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016’, provides in depth analysis on Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) targeted pipeline therapeutics. The report provides comprehensive information on the Glucose-Dependent Insulinotropi Read more

Viamet Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Apr-2016 | Global Markets Direct | Pages : 33 | Code : MRS-59705 | 1500

Viamet Pharmaceuticals, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Viamet Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Viamet Pharmaceuticals, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Viamet Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administrat Read more

OPKO Health, Inc. - Product Pipeline Review - 2016

Apr-2016 | Global Markets Direct | Pages : 81 | Code : MRS-59704 | 1500

OPKO Health, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘OPKO Health, Inc. - Product Pipeline Review - 2016’, provides an overview of the OPKO Health, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by OPKO Health, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also Read more

NewLink Genetics Corporation - Product Pipeline Review - 2016

Apr-2016 | Global Markets Direct | Pages : 53 | Code : MRS-59703 | 1500

NewLink Genetics Corporation - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘NewLink Genetics Corporation - Product Pipeline Review - 2016’, provides an overview of the NewLink Genetics Corporation’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by NewLink Genetics Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administrat Read more

Nektar Therapeutics - Product Pipeline Review - 2016

Apr-2016 | Global Markets Direct | Pages : 57 | Code : MRS-59702 | 1500

Nektar Therapeutics - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Nektar Therapeutics - Product Pipeline Review - 2016’, provides an overview of the Nektar Therapeutics’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Nektar Therapeutics, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The rep Read more

Single User | $(USD)4150 View Pricing